Volume 82 | ESPE2014 | Next issue

ESPE 2014

Dublin, Ireland
18 Sep 2014 - 20 Sep 2014

Card image cap
Dublin, Ireland; 18-20 September 2014. Further information

Poster Category 2

Growth Hormone (2)

First-year Growth Response to GH in Relation to Final Height Outcome in Prepubertal Children with Idiopathic GH Deficiency
aDepartment of Pediatric Endocrinology, University Hospital Maastricht, Maastricht, The Netherlands; bDepartment of Pediatric Endocrinology, University Hospital Antwerp, Antwerp, Belgium; cThe Belgian Study Group for Pediatric Endocrinology, Brussels, Belgium; dDepartment of Pediatric Endocrinology, University Children’s Hospital HUDE, Brussels, Belgium; eDepartment of Pediatric Endocrinology, University Hospital Brussels, Brussels, Belgium; fDepartment of Pediatric Endocrinology, University Hospital Ghent, Ghent, Belgium
hrp0082p2-d3-435
Reevaluation of GH Secretion During Puberty in Children Diagnosed as GH-deficient During Childhood
Department of Life Sciences and Reproduction Sciences, Pediatric Clinic, ‘Giambattista Rossi’ Hospital, University of Verona, Verona, Italy
hrp0082p2-d3-436
Long-Term Effects of GH Replacement Therapy on Thyroid Function in GH Deficiency Children
Pediatric Endocrinology Unit, Department of Translational Medical Sciences, University ‘Federico II’ of Naples, Naples, Italy
hrp0082p2-d3-437
GH Dosing Patterns in Short Children Born Small for Gestational Age
aHôpital des Enfants, Toulouse, France; bInstitute for Experimental Paediatric Endocrinology, Charité – Universitätsmedizin Berlin, Berlin, Germany; cSchool of Medicine, Belgrade University, Belgrade, Serbia; dInstitute for Mother and Child Health Care of Serbia, Belgrade, Serbia; eNovo Nordisk A/S, Søborg, Denmark; fNovo Nordisk Health Care AG, Zurich, Switzerland
hrp0082p2-d3-439
Two-Year Data from a Long-Term, Phase IV Study of Omnitrope®, a Recombinant Human GH, in Short Children Born Small for Gestational Age
aUniversity Children’s Hospital Munich, Munich, Germany; bMedical University, Gdansk, Poland; cChildren’s Health Research Institute, Warsaw, Poland; dPomeranian Medical University, Szczecin, Poland; eUniversity of Medicine and Pharmacy ‘Gr.T.Popa’, Iasi, Romania; fTblisi State Medical University, Tblisi, Georgia; gSandoz Biopharmaceuticals, Holzkirchen, Germany
hrp0082p2-d3-440
Effects of Gender and Gestational Age on GH Treatment in Very Young Children Born Small for Gestational Age
aFederal University of Parana, Curitiba, Brazil; bPfizer, Inc., Endocrine Care, Sollentuna, Sweden; cPfizer, Inc., Endocrine Care, Berlin, Germany
hrp0082p2-d3-441
Two-Year Results from Patro Children, a Multi-Centre, Non-Interventional Study of the Long-Term Efficacy and Safety of Omnitrope® in Children Requiring GH Treatment
aDepartment of Paediatric Endocrinology, University of Leipzig Medical School, Leipzig, Germany; bDepartment of Paediatrics, Royal Alexandra Children’s Hospital, Brighton, UK; cDepartment of Endocrinology, Metabolism and Diabetology, Karolinska University Hospital, Stockholm, Sweden; dDepartment of Clinical Science/Paediatrics, Umeå University, Umeå, Sweden; eSandoz International GmbH, Holzkirchen, Germany; fDepartment of Endocrinology, Diabetes and Metabolic Diseases, University Children’s Hospital, Llubljana, Slovenia; g25 Rue Boudet, Bordeaux, France
hrp0082p2-d3-442
The Effect of Two Different GH Dosages on Final Height and Bone Geometry
aOspedale Regionale, Bolzano, Italy; bUniversità di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; cOspedale Carlo Poma, Mantova, Italy; dSpedali Civili, Brescia, Italy
hrp0082p2-d3-443
Baseline Body Composition of Children with Short Stature Diagnosed for GH Deficiency
aDepartment of Pediatrics, Pediatric Endocrinology and Diabetes, Medical University of Silesia, Katowice, Poland; bScientific Society of Medical Students, Medical University of Silesia, Katowice, Poland
hrp0082p2-d3-444
Efficacy, Adherence, and Cost Study According to Pathology and Treatment Devices in Children Treated with GHRH
aChildren’s Endocrinology Section, Pediatric Service, Vitoria/Basque Country, Spain; bPharmacy Service, University Hospital of Alava, Vitoria/Basque Country, Spain
hrp0082p2-d3-447